Brass L F, Pizarro S, Ahuja M, Belmonte E, Blanchard N, Stadel J M, Hoxie J A
Department of Medicine, University of Pennsylvania, Philadelphia 19104.
J Biol Chem. 1994 Jan 28;269(4):2943-52.
According to current models, human thrombin receptors are activated when thrombin cleaves the receptor's N terminus, exposing the tethered ligand domain, SFLLRN. In the megakaryoblastic CHRF-288 cell line, thrombin receptor activation is followed by the rapid internalization of > 90% of the receptors. In the present studies, antibodies directed at the site of cleavage by thrombin were used to examine changes in receptor structure during activation, internalization, and recovery. As would be expected, the initial rate of receptor cleavage was directly related to the thrombin concentration. However, even after prolonged incubation, receptor cleavage was incomplete until the thrombin concentration exceeded the receptor concentration. Only cleaved receptors were internalized in response to thrombin and only catalytically active thrombin and active variants of SFLLRN-containing peptides caused receptor internalization. Over a 3-h period following receptor activation by thrombin, there was a gradual recovery of approximately one-quarter of the receptors on the cell surface. These receptors were detectable with antibodies directed at retained portions of the receptor N terminus, but not with antibodies directed at the proposed site of cleavage, confirming that they are recycled, rather than new, receptors. At 4 degrees C two-thirds of the receptors cleaved by thrombin were retained on the cell surface. Like recycled receptors these "cold-cleaved" receptors failed to self-activate when warmed to 37 degrees C, but could be activated by SFLLRN. Unlike recycled receptors, however, the cold-cleaved receptors were also internalized and appeared to be activated by a second addition of thrombin. These results 1) provide strong evidence at the protein level that thrombin cleaves its receptors at the predicted site, 2) show that receptor activation is necessary for internalization, 3) suggest that each thrombin molecule may not activate large numbers of receptors, 4) demonstrate that a substantial fraction of internalized thrombin receptors can be recycled, and 5) suggest that the failure of recycled receptors to be reactivated by thrombin may involve a change in the receptor that does not occur at 4 degrees C. Finally, the inability of cold-cleaved receptors to self activate in the absence of thrombin, suggests that in addition to cleaving the receptor, thrombin may also play an important role in guiding the tethered ligand domain to regions on the remainder of the receptor that mediate activation.
根据目前的模型,当凝血酶切割受体的N端时,人凝血酶受体被激活,从而暴露拴系配体结构域SFLLRN。在巨核母细胞CHRF-288细胞系中,凝血酶受体激活后,超过90%的受体迅速内化。在本研究中,针对凝血酶切割位点的抗体被用于检测受体在激活、内化和恢复过程中的结构变化。正如预期的那样,受体切割的初始速率与凝血酶浓度直接相关。然而,即使经过长时间孵育,在凝血酶浓度超过受体浓度之前,受体切割仍不完全。只有被切割的受体对凝血酶产生内化反应,并且只有具有催化活性的凝血酶和含SFLLRN肽的活性变体才能引起受体内化。在凝血酶激活受体后的3小时内,细胞表面约四分之一的受体逐渐恢复。这些受体可以用针对受体N端保留部分的抗体检测到,但不能用针对推测切割位点的抗体检测到,这证实它们是循环利用的受体,而非新的受体。在4℃时,三分之二被凝血酶切割的受体保留在细胞表面。与循环利用的受体一样,这些“冷切割”受体在升温至37℃时不能自我激活,但可被SFLLRN激活。然而,与循环利用的受体不同,冷切割受体也会内化,并且似乎可被再次添加的凝血酶激活。这些结果1)在蛋白质水平上提供了强有力的证据,证明凝血酶在预测位点切割其受体;2)表明受体激活是内化所必需的;3)提示每个凝血酶分子可能不会激活大量受体;4)证明相当一部分内化的凝血酶受体可以循环利用;5)提示循环利用的受体不能被凝血酶重新激活可能涉及受体在4℃时未发生的变化。最后,冷切割受体在没有凝血酶的情况下不能自我激活,这表明除了切割受体外,凝血酶在引导拴系配体结构域至受体其余部分介导激活的区域方面可能也起着重要作用。